Inhibition of human cytomegalovirus infection by IE86-specific short hairpin RNA-mediated RNA interference

Bioscience, Biotechnology and Biochemistry

Volumn 74, Issue 7, 2010, Pages 1368-1372

  Bai, Zhiqiang ^a   Li, Ling ^a   Wang, Bin ^a   Liu, Zhijun ^a   Liu, Haiyan ^a   Jiang, Guangyu ^a   Wang, Haitao ^a   Yan, Zhiyong ^a   Qian, Dongmeng ^a   Ding, Shouyi ^a   Song, Xuxia ^a  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Human cytomegalovirus; IE86; Infection; RNA interference; Short hairpin RNA

Indexed keywords

CYTOPATHIC EFFECT; HUMAN CYTOMEGALOVIRUS; INHIBITORY EFFECT; RNA INTERFERENCE; SHORT HAIRPIN RNA; THERAPEUTIC METHOD; VIRAL DNA;

VIRUSES;

RNA;

IE2 PROTEIN, CYTOMEGALOVIRUS; IMMEDIATE EARLY PROTEIN; MESSENGER RNA; SMALL INTERFERING RNA; TRANSACTIVATOR PROTEIN; VIRUS DNA;

ARTICLE; BIOSYNTHESIS; CELL LINE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; CYTOPATHOGENIC EFFECT; DNA REPLICATION; GENE THERAPY; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; HUMAN; INVERTED REPEAT; METABOLISM; PHYSIOLOGY; RNA INTERFERENCE; VIRUS REPLICATION;

CELL LINE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; CYTOPATHOGENIC EFFECT, VIRAL; DNA REPLICATION; DNA, VIRAL; GENE THERAPY; GENETIC VECTORS; HUMANS; IMMEDIATE-EARLY PROTEINS; INVERTED REPEAT SEQUENCES; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANS-ACTIVATORS; TRANSFECTION; VIRUS REPLICATION;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 77955208936     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.90966     Document Type: Article

References (28)

1. Hannon GJ, Nature, 418, 244-251 (2002).
2. Tijsterman M and Plasterk RH, Cell, 117, 1-3 (2004).
3. Kumar P, Ban HS, Kim SS, Wu H, Pearson T, Greiner DL, Laouar A, Yao J, Haridas V, Habiro K, Yang YG, Jeong JH, Lee KY, Kim YH, Kim SW, Peipp M, Fey GH, Manjunath N, Shultz LD, Lee SK, and Shankar P, Cell, 134, 577-586 (2008).
4. Meng Z, Xu Y, Wu J, Tian Y, Kemper T, Bleekmann B, Roggendorf M, Yang D, and Lu M, J. Virol. Methods, 150, 27-33 (2008).
5. Ge Q, McManus MT, Nguyen T, Shen CH, Sharp PA, Eisen HN, and Chen J, Proc. Natl. Acad. Sci. USA, 100, 2718-2723 (2003).
6. Gitlin L, Karelsky S, and Andino R, Nature, 418, 430-434 (2002).
7. Dittmer A and Bogner E, FEBS Lett., 580, 6132-6138 (2006).
8. Wiebusch L, Truss M, and Hagemeier C, J. Gen. Virol., 85, 179-184 (2004).
9. Zhu H, Shen Y, and Shenk T, J. Virol., 69, 7960-7970 (1995).
10. Castillo JP and Kowalik TF, Gene, 290, 19-34 (2002).
11. Marchini A, Liu H, and Zhu H, J. Virol., 75, 1870-1878 (2001).
12. Sanchez V, Clark CL, Yen JY, Dwarakanath R, and Spector DH, J. Virol., 76, 2973-2989 (2002).
13. White EA, Clark CL, Sanchez V, and Spector DH, J. Virol., 78, 1817-1830 (2004).
14. Choi KS, Kim SJ, and Kim S, Virology, 208, 450-456 (1995).
15. Lang D, Gebert S, Arlt H, and Stamminger T, J. Virol., 69, 6030-6037 (1995).
16. Song YJ and Stinski MF, Proc. Natl. Acad. Sci. USA, 99, 2836-2841 (2002).
17. Bresnahan WA, Albrecht T, and Thompson EA, J. Biol. Chem., 273, 22075-22082 (1998).
18. Taylor RT and Bresnahan WA, J. Virol., 79, 3873-3877 (2005).
19. Wiebusch L and Hagemeier C, EMBO J., 20, 1086-1098 (2001).
20. Murphy EA, Streblow DN, Nelson JA, and Stinski MF, J. Virol., 74, 7108-7118 (2000).
21. Hagemeier C, Caswell R, Hayhurst G, Sinclair J, and Kouzarides T, EMBO J., 13, 2897-2903 (1994).
22. Speir E, Modali R, Huang ES, Leon MB, Shawl F, Finkel T, and Epstein SE, Science, 265, 391-394 (1994).
23. Sui G, Soohoo C, Affar el B, Gay F, Shi Y, Forrester WC, and Shi Y, Proc. Natl. Acad. Sci. USA, 99, 5515-5520 (2002).
24. Yu JY, DeRuiter SL, and Turner DL, Proc. Natl. Acad. Sci. USA, 99, 6047-6052 (2002).
25. Cullen BR, Nat. Genet., 37, 1163-1165 (2005).
26. Zinke M, Kendl S, Singethan K, Fehrholz M, Reuter D, Rennick L, Herold MJ, and Schneider-Schaulies J, J. Virol., 83, 9423-9431 (2009).
27. Salvant BS, Fortunato EA, and Spector DH, J. Virol., 72, 3729-3741 (1998).
28. Gilbert C and Boivin G, Antimicrob. Agents Chemother., 49, 873-883 (2005).